Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - TOTAL RECEIVABLES
Total Receivables ESPR - Esperion Therapeutics, Inc.
48.5 M
LAST VALUE
45.41%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR